Inter-institutional heterogeneity in high-volume esophageal cancer centers: an ancillary study of JCOG1109 (JCOG2308A)
Esophagus · 2026-10 · 23 (4) · 755-762
DOI: 10.1007/s10388-026-01229-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Esophagus, online erschienen am 30.06.2026. Verfasst von Ryosuke Kita und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Hospitals, High-Volume. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Cancer Center Research and Development Fund, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background
Multimodal esophageal cancer treatment carries substantial perioperative risks. Although centralization has improved outcomes, variability may persist even among high-volume centers. This study aimed to evaluate inter-institutional heterogeneity in perioperative and survival outcomes using data from JCOG1109.
Methods
JCOG1109, a phase III multicenter trial, compared neoadjuvant cisplatin plus 5-fluorouracil (CF); docetaxel, cisplatin, and 5-fluorouracil (DCF); and cisplatin and 5-fluorouracil combined with radiotherapy (CF-RT) for stage IB–III esophageal squamous cell carcinoma. Individual patient data and institutional survey results were analyzed. Mixed-effects models with random intercepts and slopes, incorporating institutions as random effects, were applied to quantify heterogeneity in DCF and CF-RT’s treatment effects on postoperative complications, progression-free survival (PFS), and overall survival (OS), separated from baseline institutional risks in the CF arm.
Results
From 44 institutions, 580 patients were eligible and 546 underwent surgery. PFS treatment effect variance was smaller than baseline risk variability (CF: 0.062, standard deviation [SD]: 0.069; DCF: 0.044, SD: 0.053; CF-RT: 0.051, SD: 0.057), whereas OS variance exceeded baseline risk (CF: 0.058, SD: 0.068; DCF: 0.080, SD: 0.094; CF-RT: 0.072, SD: 0.079). Complication variance was lower in both experimental arms (CF: 0.342, SD: 0.432; DCF: 0.111, SD: 0.168; CF-RT: 0.190, SD: 0.326), although it was greater in the CF-RT arm than in the DCF arm.
Conclusions
Multimodal treatment was delivered with high consistency across specialized centers, as reflected by minimal heterogeneity in PFS. In contrast, moderate heterogeneity in OS indicated institutional influences, particularly post-recurrence management, which should be considered in trial designs and clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
- Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
- Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Radiation Oncology, Showa Medical University School of Medicine, Tokyo, Japan.
- Department of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan.
- Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
Förderung
- National Cancer Center Research and Development Fund
- Japan Agency for Medical Research and Development
Zitieren
APA
Kita, R., Machida, R., Fukuda, H., Kato, K., Ito, Y., Daiko, H., Ishiyama, K., Hara, H., Nishida, M., Koyanagi, K., Abe, T., Fujita, T., Bamba, T., Tsushima, T., Sasaki, K., Tsunoda, S., Hida, K., Obama, K., & Takeuchi, H. (2026). Inter-institutional heterogeneity in high-volume esophageal cancer centers: an ancillary study of JCOG1109 (JCOG2308A). Esophagus, 23(4), 755-762. https://doi.org/10.1007/s10388-026-01229-9
Vancouver
Kita R, Machida R, Fukuda H, Kato K, Ito Y, Daiko H, et al. Inter-institutional heterogeneity in high-volume esophageal cancer centers: an ancillary study of JCOG1109 (JCOG2308A). Esophagus. 2026;23(4):755-762. doi:10.1007/s10388-026-01229-9
BibTeX
@article{Kita2026,
author = {Kita, Ryosuke and Machida, Ryunosuke and Fukuda, Haruhiko and Kato, Ken and Ito, Yoshinori and Daiko, Hiroyuki and Ishiyama, Koshiro and Hara, Hiroki and Nishida, Masato and Koyanagi, Kazuo and Abe, Tetsuya and Fujita, Takeo and Bamba, Takeo and Tsushima, Takahiro and Sasaki, Keita and Tsunoda, Shigeru and Hida, Koya and Obama, Kazutaka and Takeuchi, Hiroya},
title = {Inter-institutional heterogeneity in high-volume esophageal cancer centers: an ancillary study of JCOG1109 (JCOG2308A)},
journal = {Esophagus},
year = {2026},
volume = {23},
number = {4},
pages = {755--762},
doi = {10.1007/s10388-026-01229-9}
}
EUVIMED